Gastrointestinal Cancer News

In this episode of Meeting Mic, we bring you pearls and perspectives from the 2022 ASCO Annual Meeting, as well as Healio’s top headlines from the meeting.

CHICAGO — Potentially targetable oncogenic rearrangements are more prevalent among patients with KRAS wild-type pancreatic cancer than those with KRAS-mutated disease, according to study results presented at ASCO Annual Meeting.

ASCO Annual Meeting, held in person for the first time since 2019 due to the COVID-19 pandemic, took place June 3-7 in Chicago.

Ibex Medical Analytics has obtained CE mark for Galen Gastric, an artificial intelligence-powered diagnostic solution for the detection of various types of gastric cancers, the company announced in a press release.

The AGA has released a series of evidence-based position statements that support a nationwide colorectal cancer screening approach and aim to eliminate current barriers in the screening process.

Obesity appeared associated with improved immunotherapy outcomes among patients with certain cancer types, according to a cohort study published in JAMA Network Open.

CHICAGO – Healio gathered the best, brightest and boldest group of oncologists during the ASCO Annual Meeting in Chicago to celebrate our inaugural Healio Disruptive Innovators.

In a Healio video exclusive, Chris Evans, president of the Colon Cancer Coalition and Healio’s 2021 Patient Voice Disruptive Innovator, shares updates on the organization’s recent accomplishments and future plans.

In a Healio video exclusive, Chris Evans, president of the Colon Cancer Coalition and Healio’s 2021 Patient Voice Disruptive Innovator, shares updates on the organization’s recent accomplishments and future plans.

Black patients with gastrointestinal tract cancer had a higher likelihood than their white counterparts of receiving surgical and adjuvant treatment that deviates from the standard of care, according to a study published in JAMA Network Open.